BioTalk

The United States has introduced sweeping new tariffs targeting patented pharmaceutical products and their ingredients, with duties set...

Following our recent coverage of the new US tariffs on pharmaceutical imports, it is worth noting that Europe is also seeing significant...

On 6 March 2026, the European Council published its “compromise texts of the provisional agreement” (the “Compromise Text”), setting out...

Intellectual property rights created by European Union regulations (such as supplementary protection certificates (SPC)) can give rise to...

Our foreign clients often ask us about the statute of limitations for personal injury under French law. While the question may appear...

Understanding the impact of the European Accessibility Act on Medical Devices The European Accessibility Act (Directive (EU) 2019/882)...

On 11 December 2025, it was announced that the Council of the European Union and European Parliament reached an agreement on the EU...

The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...

England’s National Health Service (NHS) is seen as one of the world’s most ambitious and comprehensive healthcare systems, but has been...

As digital health applications become increasingly sophisticated and telemedicine (the distribution of health-related information and...

As part of its pharmaceutical law reform, the EU legislator has proposed a modernised framework for combination products – products that...

This article is part of our series covering the proposed reforms to the EU pharmaceutical legislation. To view the entire series, click...

This article is part of a series covering updates to the proposed European Union (EU) pharmaceutical legislation reform, known as the...

Introduction On March 11, 2025, the European Commission introduced the Critical Medicines Act (CMA), a legislative proposal that...

In 2023, the European Commission proposed a comprehensive update of the key EU pharmaceutical legislation (the "Pharma Package") to...

On 4 June 2025, the Council of the European Union adopted its mandate for negotiations with the European Parliament on two European...